IVOS Medical Logo teal

IVOS Medical Receives SBIR Phase I Award from the National Institutes of Health 

Mar 17, 2022 | Press Release

Irvine, CA – March 17, 2022, – IVOS Medical, Inc., a startup medical device company in airway management, today announced it has been awarded $247,334 by the Small Business Innovation Research (SBIR) Phase I grant supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health. This Phase I funding will enable IVOS to continue development and test the feasibility of the company’s innovative technology.

IVOS Medical is developing an economical, disposable video laryngoscope sheath that incorporates novel features to help maintain clear vision during intubation and increase first-pass success in emergency, soiled intubations. 

DISCLAIMER: Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R43HL164325. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About IVOS Medical
IVOS Medical is a medical device company committed to advancing airway management technology, particularly for challenging intubations. Its flagship product, the patent-pending Breathing Optimization and Suction System (BOSS™) G4™, enhances critical intubation success through video laryngoscopy. IVOS Medical is dedicated to developing and elevating intubation tools with the goal of improving patient safety and healthcare efficiency. For more information, visit www.ivosmedical.com.

###

Obstructed Vision in Soiled Airways

0-11 sec:

The initial insertion of the video laryngoscope resulted in obstruction of the camera view due to fluids in the oral cavity. The device was removed from the mouth, and the lens was manually cleaned to restore the camera to baseline functionality before being reinserted.

12-21 sec:

Once the video laryngoscope was reinserted into the oral cavity, critical time had already been lost, as the simulated patient remained apneic and gastric fluids continued to enter the lungs.

22-30 sec:

A Cormack-Lehane grade 1 view was achieved after aggressive suctioning with a Yankauer suction catheter. This provided clear visualization for the healthcare provider to insert the endotracheal tube using indirect visualization.

Obstructed Vision in Soiled Airways

0-13 sec:

The video laryngoscope is equipped with the IVOS BOSS G4™ system. The device integrates gas flow into the handle to continuously provide a clear camera window throughout the entire intubation process, without requiring removal of the device from the patient’s mouth.

14-27 sec:

The G4’s integrated suction channel removes oral cavity fluids and reduces the potential for aspirate to enter the lungs. Maintaining a clear view of the airway in an emergency setting can increase first-pass success, thereby reducing morbidity and mortality in patients.

28-37 sec:

The patient remains apneic for only a minimal amount of time while the healthcare provider inserts the endotracheal tube into the trachea and secures the airway for lifesaving ventilation.